By
Drug Target Review2025-04-09T09:00:04
What if vaccines could train your immune system to eliminate infections at the source? Find out how Gylden Pharma’s gold nanoparticle platform delivers targeted T cell immunity - providing a precise and durable defence against complex infectious diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2024-03-08T10:00:25
Sponsored by Molecular Devices
2026-11-18T07:00:00
Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, By Drug Target Review
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2025-06-02T10:00:00
Contributor Professor Stefan Trapp, By Drug Target Review
2026-07-31T06:00:00
Contributor Dr Davinder Ramsingh, By Drug Target Review
Site powered by Webvision Cloud